Osama Hamadelseed

Mr. Osama Hamadelseed

Heidelberg University, Heidelberg, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
OHOsama Hamadelseed
Osama Hamadelseed
MCMike K. S. Chan
Mike K. S. Chan
MWMichelle B. F. Wong
Michelle B. F. Wong
TSThomas Skutella
Thomas Skutella
Objectives: We critically review research findings on the unique changes in brain structure and cognitive function characteristic of Down syndrome (DS) and summarize the similarities and differences with other neurodevelopmental disorders such as Williams syndrome, 22q11.2 deletion syndrome, and fragile X syndrome.Methods: We conducted a meta-analysis and systematic literature review of 84 studies identified by searching PubMed, Google Scholar, and Web of Science from 1977 to October 2022. This review focuses on the following issues: (1) specific neuroanatomic and histopathological features of DS as revealed by autopsy and modern neuroimaging modalities, (2) language and memory deficits in DS, (3) the relationships between these neuroanatomical and neuropsychological features, and (4) neuroanatomic and neuropsychological differences between DS and related neurodevelopmental syndromes.Results: Numerous post-mortem and morphometric neuroimaging investigations of individuals with DS have reported complex changes in regional brain volumes, most notably in the hippocampal formation, temporal lobe, frontal lobe, parietal lobe, and cerebellum. Moreover, neuropsychological assessments have revealed deficits in language development, emotional regulation, and memory that reflect these structural changes and are more severe than expected from general cognitive dysfunction. Individuals with DS also show relative preservation of multiple cognitive, linguistic, and social domains compared to normally developed controls and individuals with other neurodevelopmental disorders. However, all these neurodevelopment disorders exhibit substantial heterogeneity among individuals.Conclusion: People with Down syndrome demonstrate unique neurodevelopmental abnormalities but cannot be regarded as a homogenous group. A comprehensive evaluation of individual intellectual skills is essential for all individuals with neurodevelopment disorders to develop personalized care programs.

18 January 2022 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
HPHelena Rico Pereira
Helena Rico Pereira
MBMojtaba Barzegar
Mojtaba Barzegar
OHOsama Hamadelseed
Osama Hamadelseed
AVArnau Valls-Esteve
Arnau Valls-Esteve
JMJosep Munuera
Josep Munuera

21 May 2022 in Neurology and Therapy
Verified
Journal Article
Open access
PDF file
OHOsama Hamadelseed
Osama Hamadelseed
IEIbrahim H. Elkhidir
Ibrahim H. Elkhidir
TSThomas Skutella
Thomas Skutella
Several recent epidemiological studies attempted to identify risk factors for Alzheimer’s disease. Age, family history, genetic factors (APOE genotype, trisomy 21), physical activity, and a low level of schooling are significant risk factors. In this review, we summarize the known psychosocial risk factors for the development of Alzheimer’s disease in patients with Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. We completed a comprehensive review of the literature on PubMed, Google Scholar, and Web of Science about psychosocial risk factors for Alzheimer’s disease, for Alzheimer’s disease in Down syndrome, and Alzheimer’s disease in Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. Alzheimer’s disease causes early pathological changes in individuals with Down syndrome, especially in the hippocampus and corpus callosum. People with Down syndrome living with dementia showed reduced volumes of brain areas affected by Alzheimer’s disease as the hippocampus and corpus callosum in association with cognitive decline. These changes occur with increasing age, and the presence or absence of psychosocial risk factors impacts the degree of cognitive function. Correlating Alzheimer’s disease biomarkers in Down syndrome and cognitive function scores while considering the effect of psychosocial risk factors helps us identify the mechanisms leading to Alzheimer’s disease at an early age. Also, this approach enables us to create more sensitive and relevant clinical, memory, and reasoning assessments for people with Down syndrome.

26 July 2023 in Brain and Behavior
Verified
Journal Article
Open access
OHOsama Hamadelseed
Osama Hamadelseed
TSThomas Skutella
Thomas Skutella
Introduction: Down syndrome (DS) is the most common genetic cause of intellectual disability. Children and adults with DS show deficits in language performance and explicit memory. Here, we used magnetic resonance imaging (MRI) on children and adults with DS to characterize changes in the volume of specific brain structures involved in memory and language and their relationship to features of cognitive‐behavioral phenotypes.Methods: Thirteen children and adults with the DS phenotype and 12 age‐ and gender‐matched healthy controls (age range 4–25) underwent an assessment by MRI and a psychological evaluation for language and cognitive abilities.Results: The cognitive profile of people with DS showed deficits in different cognition and language domains correlating with reduced volumes of specific regional and subregional brain structures, confirming previous related studies. Interestingly, in our study, people with DS also showed more significant parahippocampal gyrus volumes, in agreement with the results found in earlier reports.Conclusions: The memory functions and language skills affected in studied individuals with DS correlate significantly with the reduced volume of specific brain regions, allowing us to understand DS's cognitive‐behavioral phenotype. Our results provide an essential basis for early intervention and the design of rehabilitation management protocols.

5 August 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
OHOsama Hamadelseed
Osama Hamadelseed
TSThomas Skutella
Thomas Skutella
Background: Down syndrome (DS) and Alzheimer’s disease (AD) are two distinct yet interconnected neurological conditions that share overlapping pathological features, including amyloid-beta plaque accumulation, neuroinflammation, and progressive neurodegeneration. Individuals with DS are at increased risk of developing AD-like dementia owing to the overexpression of the amyloid precursor protein-encoding gene on chromosome 21. Despite significant research efforts, effective disease-modifying treatments remain unavailable for both conditions, necessitating the exploration of novel therapeutic approaches. Methods: We analyzed and synthesized the existing literature on stem cell therapy as a treatment for DS and AD. We conducted a comprehensive search of PubMed, Google Scholar, and Web of Science databases, focusing on recent, high-quality, and peer-reviewed studies on stem cell therapy in DS and AD. Results: The findings indicate that stem cell therapy represents a promising therapeutic approach for both conditions. Preclinical trials using neural, mesenchymal, and induced pluripotent stem cells have shown their potential to mitigate disease pathology, restore neuronal function, modulate neuroinflammation, enhance neurogenesis, and improve cognitive performance in DS and AD models; these findings suggest the viability of stem cell-based interventions as a disease-modifying strategy. However, despite promising findings, the efficacy and safety of these approaches require further validation through well-designed human clinical trials before clinical translation. Furthermore, AD research in stem cell therapy is currently more advanced than DS research, with a greater number of preclinical and early clinical investigations. In fact, people with DS have been previously excluded from clinical trials. Conclusions: While both DS and AD share common neurodegenerative mechanisms and are potential candidates for stem cell therapeutic approaches, the therapeutic focus varies. This study underscores the potential of stem cell therapy as a novel disease-modifying approach for both conditions while emphasizing the need for further research to refine therapeutic protocols, address ethical and safety concerns, and evaluate the feasibility of translating these therapies into clinical practice.

14 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
OHOsama Hamadelseed
Osama Hamadelseed
TSThomas Skutella
Thomas Skutella
INTRODUCTION: Down syndrome is the most common genetic cause of intellectual disability. Children and adults with Down syndrome show deficits in various aspects of language performance and explicit memory. Here, we used magnetic resonance imaging (MRI) on children and adults with Down syndrome to characterize changes in the volume of specific brain structures involved in memory and language and their relationship to features of cognitive-behavioral phenotypes. METHODS: Thirteen children and adults with the Down syndrome phenotype and 12 age- and gender-matched healthy controls (age range 4-25) have assessment by MRI and underwent a psychological evaluation for language and cognitive abilities. RESULTS: The cognitive profile of people with Down syndrome showed deficits in different cognition and language domains correlated with reduced volumes of specific regional and subregional brain structures, confirming previous related studies. Interestingly, in our study, persons with Down syndrome also showed a greater parahippocampal gyrus volume, in agreement with the results found in previous reports. CONCLUSIONS: The memory functions and language skills affected in studied individuals with Down syndrome correlate significantly with the reduced volume of specific brain regions, allowing us to understand Down syndrome's cognitive-behavioral phenotype. Our results provide an essential basis for early intervention and the design of rehabilitation management protocols.